Eastman Chemical

Q2 FY2026 EarningsQ2 FY26 results beat consensus on both top and bottom lines: revenue $2.51B vs. $2.40B expected, and adjusted EPS $1.97 vs. $1.82 expected. Growth was primarily driven by the Chemical Intermediates segment, which saw a 39% YoY revenue increase and a sharp EBIT recovery due to higher pricing and lower raw material costs. Operating cash flow of $87M for H1 FY26 slightly missed the $121M consensus due to higher cash tax payments, while the full-year capex guide of ~$400M remains significantly higher than the implied quarterly consensus run-rate.